Efficacy and Safety of Everolimus (RAD001) in Patients of All Ages With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex (TSC)(EXIST-1) (EXIST-1)
This study has been completed.
First Posted: November 13, 2008
Last Update Posted: February 3, 2016
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )